JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB167372

Anti-12 Lipoxygenase/ALOX12 antibody

Be the first to review this product! Submit a review

|

(6 Publications)

Mouse Polyclonal 12 Lipoxygenase/ALOX12 antibody. Suitable for WB, ICC/IF and reacts with Human samples. Cited in 6 publications. Immunogen corresponding to Recombinant Full Length Protein corresponding to Human ALOX12.

View Alternative Names

12LO, LOG12, ALOX12, Polyunsaturated fatty acid lipoxygenase ALOX12, Arachidonate (12S)-lipoxygenase, Arachidonate (15S)-lipoxygenase, Linoleate (13S)-lipoxygenase, Lipoxin synthase 12-LO, Platelet-type lipoxygenase 12, 12S-LOX, 12S-lipoxygenase

3 Images
Immunocytochemistry/ Immunofluorescence - Anti-12 Lipoxygenase/ALOX12 antibody (AB167372)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-12 Lipoxygenase/ALOX12 antibody (AB167372)

Immunofluorescence analysis of HeLa cells labeling 12 Lipoxygenase/ALOX12 with ab167372 at 10μg/ml

Western blot - Anti-12 Lipoxygenase/ALOX12 antibody (AB167372)
  • WB

Unknown

Western blot - Anti-12 Lipoxygenase/ALOX12 antibody (AB167372)

All lanes:

Western blot - Anti-12 Lipoxygenase/ALOX12 antibody (ab167372) at 1 µg/mL

Lane 1:

12 Lipoxygenase/ALOX12 transfected 293T cell lysate at 15 µL

Lane 2:

Non-transfected 293T cell lysate at 15 µL

Secondary

All lanes:

Goat Anti-Mouse IgG (H&L)-HRP at 1/2500 dilution

Predicted band size: 76 kDa

true

Western blot - Anti-12 Lipoxygenase/ALOX12 antibody (AB167372)
  • WB

CiteAb

Western blot - Anti-12 Lipoxygenase/ALOX12 antibody (AB167372)

12 Lipoxygenase/ALOX12 western blot using anti-12 Lipoxygenase/ALOX12 antibody ab167372. Publication image and figure legend from Zhang, Q., Yan, G., et al., 2020, Mol Med, PubMed 32375633.

ab167372 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab167372 please see the product overview.

DDP-resistant ovarian cancer cells possess enhanced metastatic activity and arachidonic acid metabolism. a The procedure for the induction of DDP-resistant SKOV3 cells (upper panel); IC50 and the cell viabilities of SKOV3 and SKOV3-R with different concentrations of DDP treatment (lower panel). b, c The mRNA (b) and protein (c) levels of MRP1, MRP4, Slug and Snail in SKOV3 and SKOV3-R. d Liver metastasis in nude mice after SKOV3 or SKOV3-R subcutaneous transplantation. e, f. Migration and invasion of SKOV3 and SKOV3-R were tested by wound-healing (e) and transwell assays (f). g MRM chromatograms of AA, TXB2, 12-HETE, 5,6-EET, and 14,15-EET. h The supernatant levels of LTB4, 5-HETE, 12-HETE, PGE2, TXB2, 5,6-EET, 14,15-EET, 14,15-DHET, 11-HETE, and 11,12-DHET in SKOV3 and SKOV3-R. i The heatmap for gene expression of 12LOX, COX1, CYP2J2, COX2, 5LOX, 15LOX, LTA4H and PGDH. j the protein levels of 12LOX and COX1 were assessed by western blot. Data are expressed as mean ± SEM of 4 independent experiments. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001

false

Key facts

Host species

Mouse

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

WB, ICC/IF

applications

Immunogen

Recombinant Full Length Protein corresponding to Human ALOX12.

P18054

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1 µg/mL", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "10 µg/mL", "ICCIF-species-notes": "<p></p>" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.4 Constituents: PBS
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

12-Lipoxygenase (12-LOX) also known as ALOX12 is an enzyme that catalyzes the oxygenation of arachidonic acid to produce 12-hydroxyeicosatetraenoic acid (12-HETE). It has a molecular mass of approximately 75 kDa. This enzyme is widely expressed in various tissues including platelets lungs and pancreatic tissue. By converting polyunsaturated fatty acids such as arachidonic acid into bioactive lipids 12-LOX plays an important role in regulating cellular and physiological functions.
Biological function summary

12-LOX influences many cellular processes such as inflammation and thrombosis regulation. It is part of the lipoxygenase pathway synthesizing lipid signaling molecules that modulate immune responses and cellular growth. The enzyme does not form part of a large protein complex but interacts with lipid membranes where it exerts its catalytic function. Through its activity 12-LOX contributes to the production of eicosanoids which are signaling molecules with various physiological roles.

Pathways

12-LOX is involved in the arachidonic acid metabolism pathway and the eicosanoid signaling pathway. These pathways play roles in inflammation and immune response modulation. It works alongside other related lipoxygenases such as ALOX5 which produce different but related signaling molecules. The interaction between these enzymes helps maintain a balanced production of inflammatory mediators which controls cell proliferation and responses to external stimuli.

Alterations in 12-LOX expression or function associate strongly with cardiovascular diseases and various types of cancers. In cardiovascular disease 12-LOX-derived eicosanoids contribute to the development of atherosclerosis by promoting inflammation and endothelial dysfunction. In cancer the dysregulation of 12-LOX can lead to increased tumor growth and metastasis. These conditions often exhibit altered interactions with proteins such as COX-2 another enzyme involved in eicosanoid production highlighting the role of 12-LOX in complex disease mechanisms.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Catalyzes the regio and stereo-specific incorporation of molecular oxygen into free and esterified polyunsaturated fatty acids generating lipid hydroperoxides that can be further reduced to the corresponding hydroxy species (PubMed : 17493578, PubMed : 18311922, PubMed : 1851637, PubMed : 32404334, PubMed : 8319693, PubMed : 8500694). Mainly converts arachidonate ((5Z,8Z,11Z,14Z)-eicosatetraenoate) to the specific bioactive lipid (12S)-hydroperoxyeicosatetraenoate/(12S)-HPETE (PubMed : 17493578, PubMed : 22984144, PubMed : 24282679, PubMed : 8319693, PubMed : 8500694). Through the production of bioactive lipids like (12S)-HPETE it regulates different biological processes including platelet activation (PubMed : 8319693, PubMed : 8500694). It can also catalyze the epoxidation of double bonds of polyunsaturated fatty acids such as (14S)-hydroperoxy-docosahexaenoate/(14S)-HPDHA resulting in the formation of (13S,14S)-epoxy-DHA (PubMed : 23504711). Furthermore, it may participate in the sequential oxidations of DHA ((4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoate) to generate specialized pro-resolving mediators (SPMs) like resolvin D5 ((7S,17S)-diHPDHA) and (7S,14S)-diHPDHA, that actively down-regulate the immune response and have anti-aggregation properties with platelets (PubMed : 32404334). An additional function involves a multistep process by which it transforms leukotriene A4/LTA4 into the bioactive lipids lipoxin A4/LXA4 and lipoxin B4/LXB4, both are vasoactive and LXA4 may regulate neutrophil function via occupancy of specific recognition sites (PubMed : 8250832). Can also peroxidize linoleate ((9Z,12Z)-octadecadienoate) to (13S)-hydroperoxyoctadecadienoate/ (13S-HPODE) (By similarity). Due to its role in regulating both the expression of the vascular endothelial growth factor (VEGF, an angiogenic factor involved in the survival and metastasis of solid tumors) and the expression of integrin beta-1 (known to affect tumor cell migration and proliferation), it can be regarded as protumorigenic (PubMed : 16638750, PubMed : 22237009, PubMed : 9751607). Important for cell survival, as it may play a role not only in proliferation but also in the prevention of apoptosis in vascular smooth muscle cells (PubMed : 23578768).
See full target information ALOX12

Publications (6)

Recent publications for all applications. Explore the full list and refine your search

Phytotherapy research : PTR 38:5441-5457 PubMed39289784

2024

Geniposidic Acid Attenuates Chronic Tubulointerstitial Nephropathy Through Regulation of the NF-ƙB/Nrf2 Pathway Via Aryl Hydrocarbon Receptor Signaling.

Applications

Unspecified application

Species

Unspecified reactive species

Yan-Ni Wang,Xiao-Jun Li,Wen-Feng Wang,Liang Zou,Hua Miao,Ying-Yong Zhao

The EMBO journal 43:2337-2367 PubMed38649537

2024

SUCLG1 restricts POLRMT succinylation to enhance mitochondrial biogenesis and leukemia progression.

Applications

Unspecified application

Species

Unspecified reactive species

Weiwei Yan,Chengmei Xie,Sijun Sun,Quan Zheng,Jingyi Wang,Zihao Wang,Cheuk-Him Man,Haiyan Wang,Yunfan Yang,Tianshi Wang,Leilei Shi,Shengjie Zhang,Chen Huang,Shuangnian Xu,Yi-Ping Wang

Methods in molecular biology (Clifton, N.J.) 2712:211-222 PubMed37578709

2023

Detection of Ferroptosis by Immunohistochemistry and Immunofluorescence.

Applications

Unspecified application

Species

Unspecified reactive species

Xiao Zhong,Ruochan Chen

Frontiers in pharmacology 12:800522 PubMed35002735

2021

Shenkang Injection and Its Three Anthraquinones Ameliorates Renal Fibrosis by Simultaneous Targeting IƙB/NF-ƙB and Keap1/Nrf2 Signaling Pathways.

Applications

Unspecified application

Species

Unspecified reactive species

Liang-Pu Luo,Ping Suo,Li-Li Ren,Hong-Jiao Liu,Yamei Zhang,Ying-Yong Zhao

Clinical epigenetics 12:66 PubMed32398127

2020

Promoter methylation changes in ALOX12 and AIRE1: novel epigenetic markers for atherosclerosis.

Applications

Unspecified application

Species

Unspecified reactive species

Jee Yeon Kim,Bong-Geun Choi,Jaroslav Jelinek,Dae Hyun Kim,Seo Hyun Lee,Kwangjo Cho,Seo Hee Rha,Young Ho Lee,Hyo Sun Jin,Dae-Kyoung Choi,Geun-Eun Kim,Sun U Kwon,Junha Hwang,Jae Kwan Cha,Sukhoon Lee,Jean-Pierre J Issa,Jei Kim

Molecular medicine (Cambridge, Mass.) 26:39 PubMed32375633

2020

The SP1-12LOX axis promotes chemoresistance and metastasis of ovarian cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Qi Zhang,Guifang Yan,Juan Lei,Yu Chen,Ting Wang,Juan Gong,Yong Zhou,Huakan Zhao,Hao Chen,Yu Zhou,Lei Wu,Jiangang Zhang,Xiao Zhang,Jingchun Wang,Yongsheng Li
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com